An observational study in Temporomandibular Arthritis, sponsored by Cairo University. Status unknown at 2 sites in Egypt. Per ClinicalTrials.gov, last updated 2018-02-06.
Sponsored by Cairo University · Observational
To detect accuracy of serology in diagnosis of temporomandibular joint arthritis.
According to a search of previously published studies on accuracy of serology no sensitivity or specificity data was found regarding accurate detection of arthritis through serology, hence the aim of this study is to detect accuracy of serology in diagnosis of temporomandibular joint arthritis.
patient complaing from arthritis symptoms,an diagnosed as arthritic patient with MRI
Exclusion Criteria:
accuracy of serology
To determine the sensitivity or specificity of serology in diagnosis of temporomandibular joint arthritis
Time frame: 2 years
Rheumatoid factor
To be measured in a blood sample with (IU/mL) unit as The normal reference range for RF is less than 15 IU/mL
Time frame: 2 years
C-reactive protein
To be measured in a blood sample with (mg/dL) unit where Normal CRP levels are below 3.0 mg/dL.
Time frame: 2 years
Anti-Cyclic Citrullinated Peptide
To be measured in a blood sample with (titre-AU)
Time frame: 2 years
ANA
To be measured in a blood sample with binary outcome (positive or negative)
Time frame: 2 years
HLA-B27
To be measured in a blood sample with binary outcome (positive or negative)
Time frame: 2 years
Cellular population- type
Presence of inflammatory cells infiltrate at the synovial membrane biopsy : - type of cells
Time frame: 2 years
Cellular population- number of cells
Presence of inflammatory cells infiltrate at the synovial membrane biopsy: - mean number of cells
Time frame: 2 years
Plan to share: Undecided
No publications or documents are linked to this record.
This study is status unknown, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cairo University